D. Finzi

发表

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

J. Lisziewicz, E. Rosenberg, R. Siliciano, 1999, Nature Medicine.

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

R. Siliciano, J. Margolick, R. Brookmeyer, 1997, Nature.

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells

R. Siliciano, J. Margolick, S. Gange, 2003, Nature Medicine.

Viral Dynamics in HIV-1 Infection

R. Siliciano, D. Finzi, Robert F Siliciano, 1998, Cell.

A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.

R. Siliciano, J. Margolick, T. Pierson, 2000, The Journal of clinical investigation.

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

R Brookmeyer, R. Siliciano, J. Margolick, 1997, Science.

Progress toward curing HIV infections with hematopoietic stem cell transplantation.

D. Finzi, Sarah W. Read, C. Lane, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antiretroviral Therapy Identification of a Reservoir for HIV-1 in Patients on Highly Active

D. Finzi, 2011 .

Viral Alteration of Cellular Translational Machinery Increases Defective Ribosomal Products

J. Yewdell, J. Bennink, D. Finzi, 2007, Journal of Virology.

TruncationofKir 6 . 2 produces ATP-sensitiveK þ channels in theabsenceof the sulphonylurea receptor

R. Siliciano, J. Margolick, T. Chun, 1997 .

Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines.

R. Siliciano, R. Hruban, D. Finzi, 1994, Journal of immunology.

In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency

Robert F. Siliciano, R. Siliciano, J. Margolick, 1995, Nature Medicine.

Antiretroviral resistance during successful therapy of HIV type 1 infection.

E. Rosenberg, R. Siliciano, B. Walker, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Responses of mice to murine coronavirus immunization

D. Finzi, M. de Souza, S. Barthold, 2005, Archives of Virology.

Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir.

J. Lisziewicz, E. Rosenberg, J. Lieberman, 1999, The Journal of infectious diseases.

Quantitating protein synthesis, degradation, and endogenous antigen processing.

Shu-Bing Qian, Frank Buttgereit, J. Yewdell, 2003, Immunity.

Viral Dynamics in HIV-1 Infection Review

R. Siliciano, D. Finzi, 1998 .

Defective Virus Drives Human Immunodeficiency Virus Infection, Persistence, and Pathogenesis

D. Finzi, C. Dieffenbach, S. Plaeger, 2006, Clinical and Vaccine Immunology.

Persistence , and Pathogenesis Immunodeficiency Virus Infection , Defective Virus Drives Human

D. Finzi, C. Dieffenbach, S. Plaeger, 2006 .

Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection.

R. Siliciano, J. Margolick, T. Pierson, 2000, The Journal of infectious diseases.

Characterization of Chemokine Receptor Utilization of Viruses in the Latent Reservoir for Human Immunodeficiency Virus Type 1

Robert F. Siliciano, Janet D. Siliciano, R. Siliciano, 2000, Journal of Virology.

Defining and solving the essential protein-protein interactions in HIV infection.

D. Finzi, C. Dieffenbach, R. Basavappa, 2007, Journal of structural biology.

Taking aim at HIV replication

R. Siliciano, D. Finzi, 2000, Nature Medicine.

HIV-1 suppression by early treatment with hydroxyurea, didanosine, and a protease inhibitor

J. Lisziewicz, H. Jessen, R. Siliciano, 1998, The Lancet.